{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:25:27Z","timestamp":1791851127262,"version":"4.3.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/icu.0b013e32834bdfe2","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T23:56:21Z","timestamp":1317772581000},"page":"489-495","source":"Crossref","is-referenced-by-count":38,"title":["Ocular manifestations of systemic disease"],"prefix":"10.1097","volume":"22","author":[{"given":"Jean","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.30286","article-title":"Granulomatosis with polyangiitis (Wegeners): an alternative name for Wegeners granulomatosis.","volume":"63","author":"Falk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2010.04.003","article-title":"Microscopic polyangiitis.","volume":"36","author":"Chung","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference.","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.rdc.2010.05.003","article-title":"Clinical manifestations and treatment of Churg-Strauss syndrome.","volume":"36","author":"Baldini","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccm.2010.04.005","article-title":"The pulmonary vasculitides.","volume":"31","author":"Frankel","year":"2010","journal-title":"Clin Chest Med"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rdc.2010.05.008","article-title":"Clinical manifestations and treatment of Wegeners granulomatosis.","volume":"36","author":"Holle","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","article-title":"The antineutrophil cytoplasmic antibody-associated vasculitides.","volume":"117","author":"Seo","year":"2004","journal-title":"Am J Med"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11926-010-0137-7","article-title":"ANCA-associated small vessel vasculitis: clinical and therapeutic advances.","volume":"12","author":"Mohan","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2009.119032","article-title":"EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.","volume":"69","author":"Basu","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegeners granulomatosis.","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides.","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaut.2010.06.021","article-title":"Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegeners autoantigen.","volume":"35","author":"Silva","year":"2010","journal-title":"J Autoimmun"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","article-title":"Alpha-antitrypsin deficiency-related alleles Z and S and the risk of Wegeners granulomatosis.","volume":"62","author":"Mahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/keq375","article-title":"Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.","volume":"50","author":"Tadema","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.2009.120972","article-title":"Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database.","volume":"65","author":"Bibby","year":"2010","journal-title":"Thorax"},{"issue":"Suppl 1","key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2249.2011.04364.x","article-title":"Cyclophosphamide as induction therapy for Wegeners granulomatosis and microscopic polyangiitis.","volume":"164","author":"Langford","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2009.04.002","article-title":"Adverse effects of therapy for ANCA-associated vasculitis.","volume":"23","author":"Turnbull","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis.","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.06010809","article-title":"Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement: a prospective, open-label pilot trial.","volume":"5","author":"Silva","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis.","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0b013e32834120c1","article-title":"Plasma exchange in the treatment of Wegeners granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.","volume":"23","author":"Casian","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis.","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/art.27340","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients.","volume":"62","author":"Ribi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/lary.21121","article-title":"Intralesional corticosteroid injection and dilatation provides effective management of subglottic stenosis in Wegeners granulomatosis.","volume":"120","author":"Wolter","year":"2010","journal-title":"Laryngoscope"},{"key":"R36-10-20210206","first-page":"253","article-title":"Value of antiinfective chemoprophylaxis in primary systemic vasculitis: what is the evidence Arthritis Res T","volume":"11","author":"Moosig","year":"2009","journal-title":"her"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis.","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","article-title":"Improved outcome in 445 patients with Wegeners granulomatosis in a German vasculitis center over four decades.","volume":"63","author":"Holle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.rdc.2010.04.001","article-title":"Outcome measures in ANCA-associated vasculitis.","volume":"36","author":"Suppiah","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3).","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R42-10-20210206","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.2009.122952","article-title":"Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.","volume":"70","author":"Suppiah","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.1990.01070080087041","article-title":"Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies.","volume":"108","author":"Pulido","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/00005537-200211000-00007","article-title":"Wegeners granulomatosis of the orbit: a clinicopathological study of 15 patients.","volume":"112","author":"Fechner","year":"2002","journal-title":"Laryngoscope"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archophthalmol.2011.16","article-title":"Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease.","volume":"129","author":"Plaza","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09273940802596500","article-title":"Recalcitrant granulomatous sclerouveitis in a patient with granulomatous ANCA-associated vasculitis.","volume":"17","author":"Levy-Clarke","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archophthalmol.2011.62","article-title":"Granulomatous choroiditis in Wegener granulomatosis.","volume":"129","author":"Proia","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(01)01251-X","article-title":"Retinal and choroidal arterial occlusion in Wegeners granulomatosis.","volume":"133","author":"Iida","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archopht.1996.01100130342023","article-title":"Microscopic polyangiitis with ocular involvement.","volume":"114","author":"Caster","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R50-10-20210206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/112067210501500124","article-title":"Ocular manifestations in patients with microscopic polyangiitis.","volume":"15","author":"Mihara","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"R51-10-20210206","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MAJ.0b013e3180a5e8c6","article-title":"Microscopic polyangiitis with ocular manifestations as the initial presenting sign.","volume":"334","author":"Hara","year":"2007","journal-title":"Am J Med Sci"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICU.0b013e32834bdfe2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:48:07Z","timestamp":1621885687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00055735-201111000-00010"}},"subtitle":["antineutrophil cytoplasmic antibody-associated vasculitis"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e32834bdfe2","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}